Abstract
Nineteen adult patients with poor-risk hematologic malignancy received T cell-depleted (TCD) hematopoietic progenitor cell (HPC) transplant from partially mismatched related donors (PMRD). The preparative regimen (FITFA) included fractionated TBI, thiotepa, fludarabine, and horse (n = 3) or rabbit (n = 16) anti-thymocyte anti-sera (ATG). GVHD prophylaxis consisted of TCD by positive/negative selection using the Isolex 300i system and pre-transplant ATG with no post-transplant immunosuppression. The mean number (±s.d.) of transplanted CD34+ and CD3+ cells were 8.9 × 106/kg ±4.3 (range 2.6–19.3) and 1.4 × 104/kg ±1.2 (range 0.3–4.6) respectively. Seventeen patients evaluable for neutrophil engraftment achieved an ANC >0.5 × 109/l at a median of 12 days (range 9–27), with evidence of full donor chimerism. Thirteen patients died of the following causes: relapse (n = 6), infections (n = 5), interstitial pneumonia (n = 1), and unknown causes (n = 1) None of the recipients of rabbit ATG required therapy for acute or chronic GVHD. Five patients are alive and disease-free at a median time of 303 days post transplant (range 100–660). The FITFA preparative regimen using fractionated TBI is well tolerated and is sufficiently immunosuppressive to allow rapid and stable donor origin hematopoietic engraftment without ‘mega’ doses of CD34+ cells. Combination of stringent ex vivo TCD and pre-transplant ATG is effective GVHD prophylaxis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Biggs JC, Horowitz MM, Gale RP et al. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy Blood 1992 80: 1090 1093
Clift RA, Buckner CD, Appelbaum FR et al. Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia J Clin Oncol 1992 10: 1723 1729
Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission New Engl J Med 1994 19: 1253 1258
Anderson JE, Appelbaum FR, Fisher LD et al. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome Blood 1993 82: 677 681
Russell N, Gratwohl A, Schmitz N . The place of blood stem cells in allogeneic transplantation Br J Haematol 1996 93: 747 753
Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgastrim Blood 1995 85: 1666 1672
Russel NH, Hunter AE . Peripheral blood stem cells for allogeneic transplantation Bone Marrow Transplant 1994 13: 353 359
Beatty PG, Clift RA, Mickelson EM et al. Marrow transplantation from related donors other than HLA-identical siblings New Engl J Med 1985 313: 765 771
Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma New Engl J Med 1989 320: 197 204
Beatty PG, Dahlberg S, Mickelson EM et al. Probability of finding HLA-matched unrelated marrow donors Transplantation 1988 45: 714 718
Henslee Downey PJ . Choosing an alternative bone marrow donor among available family members Am J Pediatr Hematol Oncol 1993 15: 150 161
Ash RC, Horowitz MM, Gale RP et al. BM transplantation from related donors other than HLA-related siblings: effect of T-cell depletion Bone Marrow Transplant 1991 7: 443 452
Reisner Y, Kapoor N, Kirpatrick D et al. Transplantation for severe combined immunodeficiency with HLA-A, B, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells Blood 1983 61: 341 348
Kerman NA, Flomenberg NJ, Dupont B, O'Reilly RJ . Graft rejection in recipients of T-cell depleted HLA-nonidentical marrow transplants for leukemia: identification of host derived antidonor allotoxic T lymphocytes Transplantation 1987 43: 842 846
Soiffer RJ, Mauch P, Tarbell NJ et al. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T-cell depleted allogeneic marrow Bone Marrow Transplant 1991 7: 23 33
Gale RP, Reisner Y . Graft rejection and graft-versus-host disease: mirror images Lancet 1986 1: 1468 1470
Martin PJ . The role of donor lymphoid cells in allogeneic marrow engraftment Bone Marrow Transplant 1990 6: 283 289
Reisner Y, Martelli MF . Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells Immunol Today 1995 16: 437 440
Aversa F, Tabilio A, Terenzi A et al. Treatment of high-risk acute leukemia with T-cell depleted stem cells from related donors with one fully mismatched HLA haplotype New Engl J Med 1998 339: 1186 1193
Ruggeri L, Capanni M, Casucci M et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation Blood 1999 94: 333 339
Kraft DL, Weissman IL, Waller EK . Differentiation of CD3-4−8− human fetal thymocytes in vivo: characterization of a CD3-4+8− intermediate J Exp Med 1993 178: 265 277
Rowlings PA, Przepiorka D, Klein JP et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade Br J Haematol 1997 97: 855 864
Przepiorka D, Weisdorf D, Martin P et al. Consensus conference on acute GVHD grading Bone Marrow Transplant 1995 15: 825 828
Kaplan EL, Meier P . Non-parametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457 460
Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T-cell-depleted haploidentical three loci incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum Blood 1994 84: 3948 3955
Storb R, Raff RF, Appelbaum FR et al. Fractionated versus single dose total body irradiation at low and high dose rates to condition canine littermates for DNA-identical marrow grafts Blood 1994 83: 3384 3389
Storb R, Raff RF, Graham T et al. Marrow toxicity of fractionated versus single dose TBI is identical in canine model Int J Rad Oncol Biol Phys 1993 26: 275 283
Przepiorka D, Smith TL, Folloder J et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation Blood 1999 94: 1465 1470
Reisner Y, Martelli MF . Transplantation tolerance induced by ‘mega dose’ CD34+ cell transplants Exp Hematol 2000 28: 119 127
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Redei, I., Langston, A., Lonial, S. et al. Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34+ enriched hematopoietic progenitor cells from partially mismatched related donors. Bone Marrow Transplant 30, 335–340 (2002). https://doi.org/10.1038/sj.bmt.1703649
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703649